Submit the Ib/IIa clinical trial of LTh(αΚ) for the treatment of allergic rhinitis caused by house dust mite to Taiwan Food and Drug Administration (TFDA)

Submit the Ib/IIa clinical trial of LTh(αΚ) for the treatment of allergic rhinitis caused by house dust mite to Taiwan Food and Drug Administration (TFDA)

Submit the Ib/IIa clinical trial of LTh(αΚ) for the treatment of allergic rhinitis caused by house dust mite to Taiwan Food and Drug Administration (TFDA).

2018-09-01

Back

This site uses cookies to collect the necessary user browsing behavior so that we can provide you with a better browsing experience. Browse this site, which means you agree with "online privacy declaration."